Path Stock

Path is a health-tech company that aims to make mental healthcare accessible to everyone.

Sign up today and learn more about Path Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Path Stock

Path is a provider of a mental health and addiction treatment network for employees and their families to treat and manage Substance Use Disorder (SUD). As a perk that employers can give to their employees, the company's network enables near-instant access to expert providers of drug misuse treatment, allowing companies to decrease their healthcare expenditures. Path makes it easy to get matched instantly to a mental health provider that meets a patient’s unique requirements, including race, gender, sexuality, and language, and is covered by a patient's insurance. Patients no longer need to make numerous calls, as Path is improving mental health outcomes by simplifying the overwhelming process of finding a therapist.

Funding History

October 2019$5.3M
April 2021$17.5M
January 2022$88.0M


Co-Founder & CEO

Joshua Bruno

Co-Founder and Head of Partnerships

Gabriel Diop

VP of Product & Engineering

Anand Subramani

VP of Operations

Paul Vogelman

Investor & Advisor

Howard Charney

Head of Talent Acquisition

Natalie Lynch

VP of Clinical Operations

Brynna Pietz

Clinical Advisor

Kelly Clark

General Manager

Kevin Geehr


Barbara Wachsman

Board Director

Kevin Zhang

Member, Founding Advisory Board

Jackson Moses

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: